Form 4 for INDV Indivior Pharmaceuticals, Inc.
Accepted 2026-03-05 00:00:00 ET · period of report 2026-03-03 · accession 0001484322-26-000013 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-05 | 2026-03-03 | INDV | Burris Jeffrey W | CLO | M - OptEx | — | +79.9K | 107.5K | +289% | — |
| D | 2026-03-05 | 2026-03-03 | INDV | Burris Jeffrey W | CLO | F - Tax | $31.98 | -36.0K | 71.5K | -34% | -$1.15M |
| D | 2026-03-05 | 2026-03-03 | INDV | Burris Jeffrey W | CLO | M - OptEx | — | -104.3K | 0 | -100% | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-03-03 | M | A | 79,893 | — | 107,550 | D | — | — | (F1) Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 79,893 shares vested out of the 104.300 target amount. (F2) Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2026-03-03 | F | D | 36,032 | $31.98 | 71,518 | D | — | — | (F3) Shares used to satisfy tax withholding obligations associated with the vesting of performance stock units on March 3, 2026. |
| 3 | Derivative | Performance Stock Units | 2026-03-03 | M | D | 104,300 | — | 0 | D | $0.00 · 2026-03-03 to — | 104,300 Common Stock | (F2) Each performance stock unit represents a contingent right to receive one share of the Issuer's common stock. (F1) Represents the vesting of performance stock units upon the determination that the performance conditions were met at 76.6% with respect to the performance stock units granted to the Reporting Person on March 3, 2023, of which 79,893 shares vested out of the 104.300 target amount. |